Michael Peterson, DO
Dermatology · Spanish Fork, UTNPI 1770634909
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,633 of the $8,275 with a category attached, or 80.2%. It is spread thinly across 31 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,374, 2.9 times the $832 reported in 2019.
Across 405 payments — averaging $20.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- UCB, Inc.$2K
- Johnson & Johnson$708
- Sun Pharmaceutical Industries Inc.$567
- Lilly USA, LLC$496
- Pfizer$426
- plus $3K from 25 others
Across 604 payments — averaging $3584.37 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$851K
- Nielsen Biosciences, Inc.$531K
- Pfizer$396K
- Janssen Research & Development, LLC$68K
- Sanofi US Services Inc.$63K
- Incyte Corporation$60K
- plus $197K from 6 others
What the payments were for
- Consulting fees$1,30016%
- Food & beverage$6,63380%
- Education$3424%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 126 | $1,576 |
| UCB, Inc. | 11 | $1,525 |
| Johnson & Johnson | 32 | $708 |
| Sun Pharmaceutical Industries Inc. | 23 | $567 |
| Lilly USA, LLC | 26 | $496 |
| Pfizer | 35 | $426 |
| Novartis | 21 | $394 |
| Dermavant Sciences, Inc. | 9 | $318 |
| Galderma Laboratories, L.p. | 26 | $300 |
| Biofrontera Inc. | 13 | $274 |
| LEO Pharma Inc. | 10 | $223 |
| Arcutis Biotherapeutics, Inc. | 11 | $185 |
| Regeneron Healthcare Solutions, Inc. | 9 | $173 |
| Sanofi | 9 | $172 |
| Amgen | 9 | $169 |
| VYNE Pharmaceuticals Inc. | 2 | $118 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $113 |
| Incyte Corporation | 5 | $93 |
| E.r. Squibb & Sons, L.L.C. | 4 | $67 |
| Boston Scientific | 2 | $67 |
| Organon | 5 | $60 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $57 |
| EPI Health, LLC | 2 | $41 |
| Organogenesis Inc. | 1 | $31 |
| Dermira, Inc. | 2 | $29 |
| Strata Skin Sciences, Inc. | 2 | $23 |
| Springworks Therapeutics, Inc. | 1 | $19 |
| Medtronic | 1 | $15 |
| Genentech USA, Inc. | 1 | $15 |
| Johnson & Johnson Vision Care, Inc. | 1 | $13 |
| Janssen Scientific Affairs, LLC | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,275 in reported general payments places this provider in the 85th percentile of 163 dermatology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amjevita(Cf) AutoinjectorAdalimumab-Atto | 11 | $35,059 |
| Clobetasol Propionate | 79 | $3,421 |
| Triamcinolone Acetonide | 102 | $1,345 |
| Betamethasone Dipropionate | 19 | $816 |
| Metronidazole | 14 | $726 |
| Ketoconazole | 65 | $715 |
| Doxycycline Hyclate | 22 | $432 |
| Mupirocin | 49 | $394 |
| Clindamycin Phosphate | 12 | $335 |
| ValacyclovirValacyclovir Hcl | 17 | $294 |
| Cephalexin | 72 | $282 |
| Minoxidil | 22 | $165 |
| Hydrocortisone | 22 | $129 |
| Montelukast Sodium | 16 | $83 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $59 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Spanish Fork
- Brian WilliamsMidvale$876K
- Travis JamesProvidence$437K
- Jason HadleyBountiful$294K
- Doug Lass ForshaWest Jordan$213K
- Gerald KruegerSalt Lake City$156K
- Jamie RhoadsMurray$105K
- Kristina DuffinSalt Lake City$89K
- Mark TaylorSalt Lake City$58K
- Lori RamirezKaysville$38K
- Sancy LeachmanMurray$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.